Work from home: a mixed blessing for parents’ health during COVID-19?

The impact of telework during the coronavirus disease 2019 (COVID-19) pandemic on the general and mental health of parents.

Not Disclosed Neurodegeneration by Eli Lilly and Co for Neurodegenerative Diseases: Likelihood of Approval

Not Disclosed Neurodegeneration is under clinical development by Eli Lilly and Co and currently in Phase I for Neurodegenerative Diseases.

February 20, 2024

The Bell Labs of biotech: Stuart Schreiber has billionaire support for new biomedical institute

Every week, there is chatter of new routes to funding drug development that ultimately bring medicines to patients more quickly. On Friday, a group of

January 13, 2024

Late-stage trial supports broader use of Darzalex, blockbuster J&J multiple myeloma drug

SAN DIEGO — Johnson & Johnson’s multiple myeloma therapy, Darzalex, is already a blockbuster. Now results from a late-stage trial announced Tuesday during this year’s

December 12, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.